In principle, patients with cerebral infarction need long-term treatment with secondary prevention drugs and underlying disease control drugs to prevent stroke recurrence.
Cerebral infarction is a relatively common type of cerebrovascular disease, which affects the quality of life and safety of patients due to its high recurrence, disability and mortality. Therefore, patients with cerebral infarction need long-term standardized drug treatment to prevent its recurrence.
1. Secondary prevention drugs: For patients who have already suffered from cerebral infarction, long-term oral antithrombotic or anticoagulant drugs and plaque-stabilizing drugs are needed to prevent the recurrence of cerebral infarction. Commonly used drugs include aspirin, clopidogrel, rivaroxaban, warfarin, riscovastatin, atorvastatin and so on.
2. Drugs for basic disease control: hypertension, diabetes mellitus, hyperlipidemia, etc. are risk factors for cerebral infarction, and those who have related basic diseases need to control them well. For example, oral drugs such as timosartan should be taken to control blood pressure; oral drugs such as acarbose should be taken to control blood sugar; oral drugs such as atorvastatin should be taken to control blood lipids.
When choosing medication for cerebral infarction, patients must strictly follow the doctor’s instructions and must not blindly take it on their own, which may lead to adverse consequences.